Study directory

Depression studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
6115studies shown
Showing 2,149-2,160 of 6,115
Drug study icon
Recruitment unclearEUCTR 2021-005992-38

A randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the efficacy, safety, tolerability, and pharmacokinetics of single subcutaneous MIJ821 injection in addition to stan...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Poland
Why is this study shown?

This study is directly about Depression.

DepressionDrugA study involving a medication or substance.
Countries
Poland, Spain
Sponsor
Novartis Farmacéutica, S.A.
Condition
Depression
Other study type icon
Not recruitingISRCTN91956346

If chronic depressive patients choose their treatment... Psychoanalytic and cognitive-behavioural long-term treatment for chronic depression

This study is looking at care and outcomes for people with Chronic major depression in outpatient care, Mental and Behavioural Disorders, or Depressive episode. Taking part may give some people access to Arm 1: Preferential treatment, but direct benefit is not guaranteed.

In Germany
Why is this study shown?

This study is directly about Depression.

DepressionOther
Countries
Germany
Sponsor
German Society for Psychoanalysis, Psychotherapy, Psychosomatics and Depth Psychology (DGPT) (Germany)
Condition
Depression
Other study type icon
Not recruitingISRCTN20363887

Valdoxan ImproVes depRession with anxiEty symptoms (VIVRE)

This observational study is following people with Episodes of major depression, Mental and Behavioural Disorders, or Recurrent depression, current episode severe to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

In Germany
Why is this study shown?

This study is directly about Depression.

Depression, AnxietyOther
Countries
Germany
Sponsor
Servier Deutschland GmbH (Germany)
Condition
Depression, Anxiety
Other study type icon
Not recruitingISRCTN44890666

VITAL Germany (Valdoxan® Improves Treatment of depression and daytime Activity in real Life)

This observational study is following people with Episodes of major depression, Mental and Behavioural Disorders, or Depressive episode to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.

In Germany
Why is this study shown?

This study is directly about Depression.

DepressionOther
Countries
Germany
Sponsor
Servier Deutschland GmbH (Germany)
Condition
Depression
Drug study icon
CompletedNCT03039192

Intranasal Esketamine for depression

This study is completed in the United States, in Bulgaria, in Estonia, .... It is testing intranasal Esketamine for depression.

Multiple locations, including Birmingham
Why is this study shown?

This study is directly about Depression.

Depression, SuicidalityDrugFrom 18 Years to 64 Years
Countries
United States, Bulgaria, Estonia, ...
Sponsor
Janssen Research & Development, LLC
Condition
Depression, Suicidality
Drug study icon
CompletedNCT03097133

Intranasal Esketamine for depression

This study is completed in the United States, in France, in Canada, .... It is testing intranasal Esketamine for depression.

Multiple locations, including San Diego
Why is this study shown?

This study is directly about Depression.

Depression, SuicidalityDrugFrom 18 Years to 64 Years
Countries
United States, France, Canada, ...
Sponsor
Janssen Research & Development, LLC
Condition
Depression, Suicidality
Drug study icon
CompletedNCT04338321

A Long-term Comparison of Esketamine Nasal Spray Versus Quetiapine Extended Release, Both in Combination With a Selective Serotonin Reuptake Inhibitor/Serotonin-Norepinephrine Reuptake Inhibitor, in people with Treatment Resistant Major Depressive Disorder

This study is completed in Belgium, in Argentina, in Austria, .... It focuses on depression.

Multiple locations, including Buenos Aires
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 74 Years
Countries
Belgium, Argentina, Austria, ...
Sponsor
Janssen-Cilag International NV
Condition
Depression
Other study type icon
TerminatedNCT05109195

A Standard of Care Study of people with Major Depressive Disorder Who Have Had an Inadequate Response to a Selective Serotonin Reuptake/Serotonin-Norepinephrine Reuptake Inhibitor Antidepressant

This study was terminated in the United States and in the United Kingdom. It focuses on depression.

Multiple locations, including San Francisco
Why is this study shown?

This study is directly about Depression.

DepressionObservationalA study where researchers collect information without assigning a treatment.From 18 Years to 74 Years
Countries
United States, United Kingdom
Sponsor
Janssen Research & Development, LLC
Condition
Depression
Drug study icon
CompletedNCT04451187

Seltorexant for depression

This study is completed in Belgium and in Germany. It is testing seltorexant for depression.

Multiple locations, including Alken
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 21 Years to 80 Years
Countries
Belgium, Germany
Sponsor
Janssen Research & Development, LLC
Condition
Depression
Drug study icon
TerminatedNCT04951609

Seltorexant for depression

This study was terminated in the United States, in the United Kingdom, in Italy, .... It is testing seltorexant for depression.

Multiple locations, including Phoenix
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 12 Years to 17 Years
Countries
United States, United Kingdom, Italy, ...
Sponsor
Janssen Research & Development, LLC
Condition
Depression
Drug study icon
CompletedNCT04533529

Seltorexant for depression

This study is completed in the United States, in Brazil, in Bulgaria, .... It is testing seltorexant for depression.

Multiple locations, including Anaheim
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 74 Years
Countries
United States, Brazil, Bulgaria, ...
Sponsor
Janssen Research & Development, LLC
Condition
Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.